Jorge Santana‐Bagur

机构：University of Puerto Rico System · ORCID：0000-0003-2822-3401

发表论文 37 篇 · 总被引 1337 次 · h-index 13

代表论文

• A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial (2022 · ˜The œLancet. Gastroenterology & hepatology · 被引 111)
• Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial (2019 · The Lancet HIV · 被引 98)
• Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV (2024 · JAMA Cardiology · 被引 86)
• Long COVID Incidence Proportion in Adults and Children Between 2020 and 2024: An Electronic Health Record-Based Study From the RECOVER Initiative (2025 · Clinical Infectious Diseases · 被引 47)
• Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials (2023 · The Lancet HIV · 被引 34)
• Public Health Academic Alliance for COVID-19 Response: The Role of a National Medical Task Force in Puerto Rico (2020 · International Journal of Environmental Research and Public Health · 被引 16)